Daisuke Kohda

Daisuke Kohda

Auto-generated profile, based on publicly available information

Daisuke Kohda

Kyushu University

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2000 in Cell
Verified
Journal Article
Closed access
YAYoshito Abe
Yoshito Abe
TSToshihiro Shodai
Toshihiro Shodai
TMTakanori Muto
Takanori Muto
KMKatsuyoshi Mihara
Katsuyoshi Mihara
HTHisayoshi Torii
Hisayoshi Torii
DKDaisuke Kohda
Daisuke Kohda

15 December 2004 in Genes & Development
Verified
Journal Article
Open access
PDF file
TKTakumi Kamura
Takumi Kamura
KMKatsumi Maenaka
Katsumi Maenaka
SKShuhei Kotoshiba
Shuhei Kotoshiba
MMMasaki Matsumoto
Masaki Matsumoto
DKDaisuke Kohda
Daisuke Kohda
KNKeiichi I. Nakayama
Keiichi I. Nakayama
The ECS (Elongin B/C-Cul2/Cul5-SOCS-box protein) complex is a member of a family of ubiquitin ligases that share a Cullin-Rbx module. SOCS-box proteins recruit substrates to the ECS complex and are linked to Cullin-Rbx via Elongin B/C. VHL has been implicated as a SOCS-box protein, but lacks a C-terminal sequence (downstream of the BC box) of the SOCS box. We now show that VHL specifically interacts with endogenous Cul2-Rbx1 in mammalian cells, whereas SOCS-box proteins associate with Cul5-Rbx2. We also identify LRR-1 and FEM1B as proteins that share a region of homology with VHL (the VHL box, including the BC box and downstream residues) and associate with Cul2-Rbx1. ECS complexes can thus be classified into two distinct protein assemblies, that is, those that contain a subunit with a VHL box (composed of the BC box and a downstream Cul2 box) that interacts with Cul2-Rbx1, and those that contain a subunit with a SOCS box (BC box and downstream Cul5 box) that interacts with Cul5-Rbx2. Domain-swapping analyses showed that the specificity of interaction of VHL-box and SOCS-box proteins with Cullin-Rbx modules is determined by the Cul2 and Cul5 boxes, respectively. Finally, RNAi-mediated knockdown of the Cul2-Rbx1 inhibited the VHL-mediated degradation of HIF-2α, whereas knockdown of Cul5-Rbx2 did not affect it. These data suggest that the functions of the Cul2-Rbx1 and Cul5-Rbx2 modules are distinct.

31 October 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MSMitsunori Shiroishi
Mitsunori Shiroishi
KKKimiko Kuroki
Kimiko Kuroki
LRLinda Rasubala
Linda Rasubala
KTKouhei Tsumoto
Kouhei Tsumoto
IKIzumi Kumagai
Izumi Kumagai
KMKatsumi Maenaka
Katsumi Maenaka
HLA-G is a nonclassical MHC class I (MHCI) molecule that can suppress a wide range of immune responses in the maternal–fetal interface. The human inhibitory immune receptors leukocyte Ig-like receptor (LILR) B1 [also called LIR1, Ig-like transcript 2 (ILT2), or CD85j] and LILRB2 (LIR2/ILT4/CD85d) preferentially recognize HLA-G. HLA-G inherently exhibits various forms, including β2-microglobulin (β2m)-free and disulfide-linked dimer forms. Notably, LILRB1 cannot recognize the β2m-free form of HLA-G or HLA-B27, but LILRB2 can recognize the β2m-free form of HLA-B27. To date, the structural basis for HLA-G/LILR recognition remains to be examined. Here, we report the 2.5-Å resolution crystal structure of the LILRB2/HLA-G complex. LILRB2 exhibits an overlapping but distinct MHCI recognition mode compared with LILRB1 and dominantly recognizes the hydrophobic site of the HLA-G α3 domain. NMR binding studies also confirmed these LILR recognition differences on both conformed (heavy chain/peptide/β2m) and free forms of β2m. Binding studies using β2m-free MHCIs revealed differential β2m-dependent LILR-binding specificities. These results suggest that subtle structural differences between LILRB family members cause the distinct binding specificities to various forms of HLA-G and other MHCIs, which may in turn regulate immune suppression.

1 September 1996 in Cell
Verified
Journal Article
Closed access
DKDaisuke Kohda
Daisuke Kohda
CMCraig Morton
Craig Morton
APAshfaq A Parkar
Ashfaq A Parkar
HHHideki Hatanaka
Hideki Hatanaka
FIFuyuhiko M Inagaki
Fuyuhiko M Inagaki
ADAnthony Day
Anthony Day

4 December 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
THTakao Hashiguchi
Takao Hashiguchi
MKMizuho Kajikawa
Mizuho Kajikawa
NMNobuo Maita
Nobuo Maita
Makoto TakedaMakoto Takeda
Makoto Takeda
KKKimiko Kuroki
Kimiko Kuroki
KMKatsumi Maenaka
Katsumi Maenaka
Measles still remains a major cause of childhood morbidity and mortality worldwide. Measles virus (MV) vaccines are highly successful, but the mechanism underlying their efficacy has been unclear. Here we report the crystal structure of the MV attachment protein, hemagglutinin, responsible for MV entry. The receptor-binding head domain exhibits a cubic-shaped β-propeller structure and forms a homodimer. N-linked sugars appear to mask the broad regions and cause the two molecules forming the dimer to tilt oppositely toward the horizontal plane. Accordingly, residues of the putative receptor-binding site, highly conserved among MV strains, are strategically positioned in the unshielded area of the protein. These conserved residues also serve as epitopes for neutralizing antibodies, ensuring the serological monotype, a basis for effective MV vaccines. Our findings suggest that sugar moieties in the MV hemagglutinin critically modulate virus–receptor interaction as well as antiviral antibody responses, differently from sugars of the HIV gp120, which allow for immune evasion.

1 April 2006 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MSMitsunori Shiroishi
Mitsunori Shiroishi
KKKimiko Kuroki
Kimiko Kuroki
TOToyoyuki Ose
Toyoyuki Ose
LRLinda Rasubala
Linda Rasubala
ISIkuo Shiratori
Ikuo Shiratori
KMKatsumi Maenaka
Katsumi Maenaka
HLA-G is a nonclassical major histocompatibility complex class I (MHCI) molecule, which is expressed in trophoblasts and confers immunological tolerance in the maternal-fetal interface by binding to leukocyte Ig-like receptors (LILRs, also called as LIR/ILT/CD85) and CD8. HLA-G is expressed in disulfide-linked dimer form both in solution and at the cell surface. Interestingly, MHCI dimer formations have been involved in pathogenesis and T cell activation. The structure and receptor binding characteristics of MHCI dimers have never been evaluated. Here we performed binding studies showing that the HLA-G dimer exhibited higher overall affinity to LILRB1/2 than the monomer by significant avidity effects. Furthermore, the cell reporter assay demonstrated that the dimer formation remarkably enhanced the LILRB1-mediated signaling at the cellular level. We further determined the crystal structure of the wild-type dimer of HLA-G with the intermolecular Cys(42)-Cys(42) disulfide bond. This dimer structure showed the oblique configuration to expose two LILR/CD8-binding sites upward from the membrane easily accessible for receptors, providing plausible 1:2 (HLA-G dimer:receptors) complex models. These results indicated that the HLA-G dimer conferred increased avidity in a proper structural orientation to induce efficient LILR signaling, resulting in the dominant immunosuppressive effects. Moreover, structural and functional implications for other MHCI dimers observed in activated T cells and the pathogenic allele, HLA-B27, are discussed.